Nalaganje...
Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment trial
INTRODUCTION: The Strategic Timing of AntiRetroviral Treatment (START) trial has recruited antiretroviral-naïve individuals with high CD4 cell counts from all world regions. We describe the distribution of cardiovascular (CVD) risk factors, overall and by geographic region, at study baseline. METHOD...
Shranjeno v:
| izdano v: | HIV Med |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4341949/ https://ncbi.nlm.nih.gov/pubmed/25711323 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hiv.12233 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|